Crohn’s Disease Exclusion Diet: Clinical implementation & evolving evidence
US dietitians:
“Crohn’s Disease Exclusion Diet: Clinical implementation & evolving evidence”awards 1.0 CPEUs in accordance with the Commission on Dietetic Registration’s CPEU Prior Approval Program.
The CPEUs for the live event expires November 11, 2027.
Australian/NZ dietitians:
CPD hours are applicable for Australia and New Zealand dietitians.
Other healthcare professionals:
Check your local country requirements to see if you can claim for continuing education.
About the webinar:
Exclusive enteral nutrition has long been an established therapy to induce remission in Crohn’s disease. As research and clinical practice have evolved, the Crohn’s Disease Exclusion Diet (CDED) now gives dietitians a food-based alternative to meet patients’ needs, typically paired with partial enteral nutrition (PEN). Today, CDED + PEN is included in ESPEN, ECCO, and ESPGHAN recommendations for mild-to-moderate disease in children and adults.
Join Dr. Rotem Sigall-Boneh, clinical and research dietitian and co-developer of CDED, as she reviews how the diet has evolved over time and how to efficiently apply it in practice. We’ll cover implementation in children and adults, cultural adaptations, therapy duration and adherence, and the emerging research on CDED and the gut microbiome.
After the webinar, attendees will be able to:
- Explain the evidence and current ESPEN, ECCO, and ESPGHAN recommendations for the Crohn’s Disease Exclusion Diet (CDED)
- Identify which patients and clinical settings may benefit from CDED, and when it may be used alone or alongside pharmacological and biologic therapies
- Adapt CDED for children and adults across cultures and clinical settings, balancing whole foods, dietary restriction, and partial enteral nutrition to meet patients’ needs
About the speaker:
Dr. Rotem Sigall-Boneh, PhD, RD (Israel) is a clinical and research dietitian and co-founder of the Crohn’s Disease Exclusion Diet (CDED), specializing in nutritional therapy for inflammatory bowel disease (IBD). She established and led the Pediatric Gastroenterology and Nutrition Research Unit at the Wolfson Medical Center in Israel, and has extensive experience in clinical research on dietary therapies for Crohn’s disease in children and adults.
She completed her PhD at Amsterdam UMC, University of Amsterdam, focusing on the biology, effectiveness, and clinical application of CDED. Dr. Sigall-Boneh is the founder and former chair of D-ECCO, the dietitians’ committee of the European Crohn’s and Colitis Organisation (ECCO), and a member of the ESPGHAN Porto IBD Group and the United European Gastroenterology Public Affairs Group. She has contributed to several international clinical guidelines and consensus statements on nutritional and medical management of IBD.
Supported by
The content, products and/or services referred to in this session are intended for Health Care Professionals only and are not, and are not intended to be, medical advice, which should be tailored to your individual circumstances. The content is for your information only, and we advise that you exercise your own judgement before deciding to use the information provided. Professional medical advice should be obtained before taking action. Any references to particular products and/or services in this session does not constitute any form of endorsement. Please see here for terms and conditions.
| Continuing Education (USA) | |
|---|---|
| Duration | 1 hour |
| CPEUs Awarded | 1.0 |
| Performance Indicators | 9.1.1, 9.2.1, 11.3.7 |